139 related articles for article (PubMed ID: 38788029)
21. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
[TBL] [Abstract][Full Text] [Related]
22. Thyroid Laboratory Testing and Management in Women on Thyroid Replacement Before Pregnancy and Associated Pregnancy Outcomes.
Lemieux P; Yamamoto JM; Nerenberg KA; Metcalfe A; Chin A; Khurana R; Donovan LE
Thyroid; 2021 May; 31(5):841-849. PubMed ID: 33108964
[No Abstract] [Full Text] [Related]
23. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
[TBL] [Abstract][Full Text] [Related]
24. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.
Abalovich M; Vázquez A; Alcaraz G; Kitaigrodsky A; Szuman G; Calabrese C; Astarita G; Frydman M; Gutiérrez S
Thyroid; 2013 Nov; 23(11):1479-83. PubMed ID: 23731335
[TBL] [Abstract][Full Text] [Related]
25. [Research of relationship between thyroid-stimulating hormone level after surgery and hypercholesterolemia in female patients with differentiated thyroid cancer].
Zhang B; Geng L; Lin H; Jia Q; Li T
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 34(6):554-557. PubMed ID: 32842190
[No Abstract] [Full Text] [Related]
26. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
[TBL] [Abstract][Full Text] [Related]
27. A pre-ablative thyroid-stimulating hormone with 30-70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients.
Xiao J; Yun C; Cao J; Ding S; Shao C; Wang L; Huang F; Jia H
Sci Rep; 2021 Jan; 11(1):1348. PubMed ID: 33446744
[TBL] [Abstract][Full Text] [Related]
28. Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.
Do Cao C; Wémeau JL
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S47-52. PubMed ID: 26826483
[TBL] [Abstract][Full Text] [Related]
29. Patient-Tailored Levothyroxine Dosage with Pharmacokinetic/Pharmacodynamic Modeling: A Novel Approach After Total Thyroidectomy.
Brun VH; Eriksen AH; Selseth R; Johansson K; Vik R; Davidsen B; Kaut M; Hellemo L
Thyroid; 2021 Sep; 31(9):1297-1304. PubMed ID: 33980057
[No Abstract] [Full Text] [Related]
30. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
Zhang Q; Zhong ZZ; Wu T; He YQ
BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
[TBL] [Abstract][Full Text] [Related]
31. IMPACT OF RAMADAN FASTING ON THYROID STATUS AND QUALITY OF LIFE IN PATIENTS WITH PRIMARY HYPOTHYROIDISM: A PROSPECTIVE COHORT STUDY FROM KARACHI, PAKISTAN.
Sheikh A; Mawani M; Mahar SA
Endocr Pract; 2018 Oct; 24(10):882-888. PubMed ID: 29975574
[TBL] [Abstract][Full Text] [Related]
32. Comparison of reproductive outcomes in subclinical hypothyroidism women with high-normal versus low-normal thyroid-stimulating hormone levels after treatment with levothyroxine.
Zhang Y; Liu Y; Li Z; Guan Y
Clin Endocrinol (Oxf); 2023 Mar; 98(3):426-435. PubMed ID: 35902367
[TBL] [Abstract][Full Text] [Related]
33. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
[TBL] [Abstract][Full Text] [Related]
35. Analysis of dose-TSH response effect of levothyroxine soft-gel formulation.
Trimboli P; Piticchio T; Dadda Z; Stramazzo I; Gamarra E; Ruinelli L; Virili C
Front Endocrinol (Lausanne); 2024; 15():1340204. PubMed ID: 38449850
[TBL] [Abstract][Full Text] [Related]
36. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma.
Wang LY; Smith AW; Palmer FL; Tuttle RM; Mahrous A; Nixon IJ; Patel SG; Ganly I; Fagin JA; Boucai L
Thyroid; 2015 Mar; 25(3):300-7. PubMed ID: 25386760
[TBL] [Abstract][Full Text] [Related]
37. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.
Sachmechi I; Reich DM; Aninyei M; Wibowo F; Gupta G; Kim PJ
Endocr Pract; 2007; 13(4):345-9. PubMed ID: 17669709
[TBL] [Abstract][Full Text] [Related]
38. Risk of over- and under- treatment with levothyroxine in primary care in Copenhagen, Denmark.
la Cour JL; Medici BR; Grand MK; Nicolaisdottir DR; Lind B; Faber J; Andersen CL; Nygaard B
Eur J Endocrinol; 2021 Oct; 185(5):673-679. PubMed ID: 34478406
[TBL] [Abstract][Full Text] [Related]
39. Preparation for radioactive iodine administration in differentiated thyroid cancer patients.
Liel Y
Clin Endocrinol (Oxf); 2002 Oct; 57(4):523-7. PubMed ID: 12354135
[TBL] [Abstract][Full Text] [Related]
40. Management of Subclinical Hypothyroidism: A Focus on Proven Health Effects in the 2023 Korean Thyroid Association Guidelines.
Ku EJ; Yoo WS; Chung HK
Endocrinol Metab (Seoul); 2023 Aug; 38(4):381-391. PubMed ID: 37550859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
